Thane Kreiner

Thane Kreiner, Ph.D., is currently Executive Director of the Center for Science, Technology and Society at Santa Clara University. Thane was most recently Founder, President and CEO of PhyloTech, Inc., which conducts comprehensive microbial community analysis for environmental and human health applications. He was Founder, President and CEO of Presage Biosciences, Inc., a Seattle-based company dedicated to bringing better cancer drugs to market. Thane was also the start-up President & CEO for iZumi Bio, Inc. (now iPierian), a regenerative medicine venture based on the break-through iPSc (induced pluripotent stem cell) technology. Prior to his efforts as a “parallel entrepreneur”, Thane spent 14 years in various senior leadership roles at Affymetrix, Inc., which pioneered the DNA chip industry. Thane earned his MBA from the Stanford Graduate School of Business; his Ph.D. in Neurosciences from Stanford University’s School of Medicine; and his B.S. in Chemistry from the University of Texas at Austin.